The survival signals generated by ATX through subsequent signaling through LPA receptors on tumor-associated cells decrease the efficacies of pacitaxel [65], tamoxifen [112], and doxorubicin [113] in killing the breast cancer cells. Here, ENPP2 is linked to neoplasm.